全文获取类型
收费全文 | 75801篇 |
免费 | 5955篇 |
国内免费 | 333篇 |
专业分类
耳鼻咽喉 | 973篇 |
儿科学 | 2271篇 |
妇产科学 | 1487篇 |
基础医学 | 9521篇 |
口腔科学 | 1213篇 |
临床医学 | 7525篇 |
内科学 | 16067篇 |
皮肤病学 | 1034篇 |
神经病学 | 6723篇 |
特种医学 | 2661篇 |
外科学 | 12190篇 |
综合类 | 1630篇 |
现状与发展 | 1篇 |
一般理论 | 54篇 |
预防医学 | 5558篇 |
眼科学 | 1878篇 |
药学 | 5387篇 |
1篇 | |
中国医学 | 187篇 |
肿瘤学 | 5728篇 |
出版年
2023年 | 430篇 |
2022年 | 707篇 |
2021年 | 1882篇 |
2020年 | 1119篇 |
2019年 | 1749篇 |
2018年 | 2074篇 |
2017年 | 1427篇 |
2016年 | 1658篇 |
2015年 | 1971篇 |
2014年 | 2633篇 |
2013年 | 3351篇 |
2012年 | 5532篇 |
2011年 | 5662篇 |
2010年 | 3199篇 |
2009年 | 2831篇 |
2008年 | 4801篇 |
2007年 | 4826篇 |
2006年 | 4642篇 |
2005年 | 4598篇 |
2004年 | 4265篇 |
2003年 | 3956篇 |
2002年 | 3562篇 |
2001年 | 1528篇 |
2000年 | 1301篇 |
1999年 | 1255篇 |
1998年 | 789篇 |
1997年 | 657篇 |
1996年 | 557篇 |
1995年 | 546篇 |
1994年 | 475篇 |
1993年 | 431篇 |
1992年 | 745篇 |
1991年 | 677篇 |
1990年 | 617篇 |
1989年 | 572篇 |
1988年 | 523篇 |
1987年 | 473篇 |
1986年 | 460篇 |
1985年 | 448篇 |
1984年 | 357篇 |
1983年 | 318篇 |
1982年 | 286篇 |
1981年 | 256篇 |
1980年 | 217篇 |
1979年 | 235篇 |
1978年 | 165篇 |
1977年 | 174篇 |
1976年 | 130篇 |
1974年 | 120篇 |
1973年 | 128篇 |
排序方式: 共有10000条查询结果,搜索用时 734 毫秒
11.
Xin Yi Wong Andrew Qi Jun Lim Qianyu Shen John Whay Kuang Chia Min Hoe Chew Wah Siew Tan 《Current medical research and opinion》2020,36(10):1677-1686
Abstract
Objective
Ras wild-type metastatic colorectal cancers (mCRC) may be treated with anti-vascular endothelial growth factor (VEGF) or anti-epidermal growth factor receptor (EGFR) agents. We aim to estimate patients’ preferences for mCRC treatment and relative importance of cost, efficacy improvement, avoidance of side effects and therapy convenience, and relative uptake between profiles that resemble Bevacizumab (anti-VEGF) and Cetuximab (anti-EGFR), two commonly prescribed mCRC targeted therapies. 相似文献12.
13.
Methicillin‐resistant Staphylococcus aureus eradication in young infants should include the diaper area and treat housing contacts 下载免费PDF全文
14.
15.
16.
17.
PNPLA3 gene polymorphism and response to lifestyle modification in patients with nonalcoholic fatty liver disease 下载免费PDF全文
18.
Tien‐Yao Tsai Iat‐Lon Leong Ka‐Shun Cheng Lian‐Ru Shiao Tzu‐Hui Su Kar‐Lok Wong Paul Chan Yuk‐Man Leung 《Fundamental & clinical pharmacology》2019,33(1):52-62
A pathological feature in atherosclerosis is the dysfunction and death of vascular endothelial cells (EC). Oxidized low‐density lipoprotein (LDL), known to accumulate in the atherosclerotic arterial walls, impairs endothelium‐dependent relaxation and causes EC apoptosis. A major bioactive ingredient of the oxidized LDL is lysophosphatidylcholine (LPC), which at higher concentrations causes apoptosis and necrosis in various EC. There is hitherto no report on LPC‐induced cytotoxicity in brain EC. In this work, we found that LPC caused cytosolic Ca2+ overload, mitochondrial membrane potential decrease, p38 activation, caspase 3 activation and eventually apoptotic death in mouse cerebral bEND.3 EC. In contrast to reported reactive oxygen species (ROS) generation by LPC in other EC, LPC did not trigger ROS formation in bEND.3 cells. Pharmacological inhibition of p38 alleviated LPC‐inflicted cell death. We examined whether heparin could be cytoprotective: although it could not suppress LPC‐triggered Ca2+ signal, p38 activation and mitochondrial membrane potential drop, it did suppress LPC‐induced caspase 3 activation and alleviate LPC‐inflicted cytotoxicity. Our data suggest LPC apoptotic death mechanisms in bEND.3 might involve mitochondrial membrane potential decrease and p38 activation. Heparin is protective against LPC cytotoxicity and might intervene steps between mitochondrial membrane potential drop/p38 activation and caspase 3 activation. 相似文献
19.
20.
Mariano E. Menendez Suleiman Y. Sudah Patrick J. Denard 《Seminars in Arthroplasty》2022,32(3):644-649
BackgroundThe growing enthusiasm for the use of reverse shoulder arthroplasty (RSA) in the treatment of primary glenohumeral osteoarthritis (GHOA) with an intact rotator cuff is based on data derived from single-center studies with limited generalizability and follow-up. This study compared patient-reported outcomes (PROs) between RSA and total shoulder arthroplasty (TSA) for the treatment of primary GHOA with up to 5-year follow-up and examined temporal trends in the treatment of GHOA between 2012 and 2021.MethodsA retrospective review was performed on patients with primary GHOA undergoing primary arthroplasty surgery from the Surgical Outcomes System global registry between 2012 and 2021. PROs including the American Shoulder and Elbow Surgeons (ASES) score, Single Assessment Numeric Evaluation (SANE) score, and visual analog scale (VAS) for pain were compared between RSA and TSA at 1, 2, and 5 years postoperatively.ResultsA total of 4451 patients were included, with 2693 (60.5%) undergoing TSA and 1758 (39.5%) undergoing RSA. Both RSA and TSA provided clinically excellent outcomes at 1 year postoperatively (ASES: 80.8 ± 17.9 vs. 85.9 ± 15.2, respectively; SANE: 74.8 ± 24.7 vs. 79.5 ± 22.9; VAS pain: 1.3 ± 2.0 vs. 1.1 ± 1.7; all P < .05) that were maintained at 2 years (ASES: 81.3 ± 19.3 vs. 87.3 ± 14.9; SANE: 74.8 ± 26.2 vs. 79.7 ± 24.7; VAS pain: 1.3 ± 2.1 vs. 1.0 ± 1.6; all P < .05) and 5 years (ASES: 81.7 ± 16.5 vs. 86.9 ± 15.3; SANE: 71.6 ± 28.5 vs. 78.2 ± 25.9; VAS pain: 1.0 ± 1.7 vs. 1.0 ± 1.7; all P < .05), with statistical significance favoring TSA. After controlling for age and sex, there was an adjusted difference of 4.5 units in the ASES score favoring TSA (P = .005) at 5 years postoperatively but no differences in adjusted SANE (P = .745) and VAS pain (P = .332) scores. The use of RSA for GHOA grew considerably over time, from representing only 17% of all replacements performed for GHOA in 2012 to nearly half (47%) in 2021 (P < .001).ConclusionRSA as a treatment for GHOA with an intact rotator cuff seems to yield PROs that are largely clinically equivalent to TSA extending to 5 years postoperatively. The observed statistical significance favoring TSA appears to be of marginal clinical benefit based on established minimal clinically important differences and may be a result of the large sample size. Further research using more granular clinical data and examining differences in range of motion and complications is warranted as it may change the value analysis. 相似文献